Detalhe da pesquisa
1.
The immune cell landscape in kidneys of patients with lupus nephritis.
Nat Immunol
; 20(7): 902-914, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209404
2.
Publisher Correction: The immune cell landscape in kidneys of patients with lupus nephritis.
Nat Immunol
; 20(10): 1404, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409923
3.
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II).
Lancet
; 401(10381): 1011-1019, 2023 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36848919
4.
Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Ann Rheum Dis
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754981
5.
What Bedside Skills Could the Modern Rheumatologist Possess? Part I. The Basics.
J Clin Rheumatol
; 2023 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37553898
6.
What Bedside Skills Could the Modern Rheumatologist Possess? Part II. "Certain Technical Procedures".
J Clin Rheumatol
; 2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37983677
7.
Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials.
Ann Rheum Dis
; 81(7): 951-961, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35338035
8.
Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials.
Ann Rheum Dis
; 81(7): 962-969, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35580976
9.
Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus.
Ann Rheum Dis
; 2022 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35798534
10.
Regarding Arthroscopy: Can Orthopedists and Rheumatologists Be Friends?
J Clin Rheumatol
; 28(3): 177-181, 2022 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325902
11.
Arthroscopy in rheumatology: where have we been? Where might we go?
Rheumatology (Oxford)
; 60(2): 518-528, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33257961
12.
Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach.
Ann Rheum Dis
; 79(3): 356-362, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31915121
13.
Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.
J Autoimmun
; 106: 102340, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31629628
14.
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.
Lancet
; 392(10143): 222-231, 2018 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30043749
15.
Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen.
Rheumatology (Oxford)
; 58(7): 1259-1267, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30753683
16.
Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial.
Ann Rheum Dis
; 77(6): 883-889, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29563108
17.
Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index.
Rheumatology (Oxford)
; 57(1): 125-133, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045736
18.
Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort.
Rheumatology (Oxford)
; 57(4): 677-687, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29361147
19.
Current advances in therapies for osteoarthritis.
Curr Opin Rheumatol
; 28(3): 246-50, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27022820
20.
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).
Ann Rheum Dis
; 75(1): 196-202, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26038091